An interventional study of Phone Calls in Frailty, Cardiac Surgery and QALYs, sponsored by University Hospital, Bordeaux. Recruiting at 1 site in France. Open to participants aged 75 Years and older. Per ClinicalTrials.gov, last updated 2026-06-30.
Sponsored by University Hospital, Bordeaux · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 59 studies in Frailty with a site in France — 23 open to participants now, 25 under way, none of them phase 3. Frailty · France.
Among the 59 studies in Frailty with a site in France, this one is the 8th largest by planned enrollment of the 27 interventional ones that give a count, is one of 10 that started in 2025, is one of 27 with no phase, reaches primary completion later than 19 of the 24 other live ones, and was the 56th registered.
1,291 studies on the registry are indexed under Frailty; 454 are open to participants now.
Browse Frailty studies →23 of the 59 studies in Frailty with a site in France are open now. Recruiting first, the newest first:
Fondation Hôpital Saint-Joseph · Sites in France
Ages 18+
University Hospital, Grenoble · Sites in France
Ages 70+
University Hospital, Toulouse · Sites in France
Ages 70+
Centre Hospitalier Universitaire de Saint Etienne · Sites in France
Ages 65+
Groupe Hospitalier du Havre · Sites in France, Belgium
Ages 50+
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 299 Frailty studies recruiting now, 235 (79%) set no upper age limit and 10 (3%) stop at 75 or younger; 7 take children under 18; 66 take healthy volunteers.
This study: 75 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
59 studies; the count open now beside each. This study's row is marked.
First in 2006; this study’s year is marked. 10 started in 2025.
This study's planned enrollment of 265 is above the median of 83 across 772 interventional studies indexed under Frailty.
Median enrollment 106 across the 27 interventional studies, 200 across the 32 observational. Of the 29 that completed or were terminated, 1 (3%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 59 have an industry lead sponsor. The 10 most frequent:
University Hospital, Bordeaux is the lead sponsor of 807 studies on the registry; 198 are open to participants now.
University Hospital, Bordeaux has 2 studies filed under Frailty — fewer than ten, so there is no comparison to draw.
7 of the studies in Frailty with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06247189University Hospital, ToulouseICOPE Program Feasibility in the Management of Myeloma Patients | 2026-12-03 |
| NCT06513130University Hospital, Strasbourg, FranceGeriatric Assessment at Discharge From the Intensive Care Unit in Patients Aged 75 Years and Older: a Feasibility Study | 2027-01-02 |
| NCT06887075University Hospital, BordeauxSystemic Activation of Inflammasomes and Frailty in Older Candidates to Kidney Transplantation | 2027-02-15 |
| NCT07348081Fondation Hôpital Saint-JosephReal World Evidence to Assess the Value of a Digital Care Coordination and Monitoring Program for Supporting Caregivers of Adults Discharged From the Emergency Department. | 2027-03-12 |
| NCT07379099MSPU de Pins-JustaretImplementation of the Personalized Care Plan (PCP) Proposed at the End of Step 2 of the ICOPE Program | 2027-06-01 |
Add all 7 to your calendar (.ics) → With an account.
Among the 59 studies in Frailty with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The hypothesis is that the preoperative Clinical Frailty Score (CFS) is a predictive factor for a loss in quality-adjusted life years (QALYs) one year after emergency cardiac surgery under cardiopulmonary bypass (CPB) in patients aged 75 years and older.
The advancement of structural cardiology, particularly with percutaneous valve interventions, offers new treatment options without the need for cardiopulmonary bypass (CPB). Despite an increase in the use of these techniques, some studies highlight a notable rise in CPB usage in patients aged 80 and over, from 13.8% in 2013 to 20.5% in 2022. In France, the population aged 85 and above is expected to triple by 2050, meaning more elderly patients will be eligible for CPB cardiac surgery. Several global studies have examined the outcomes of older individuals undergoing CPB cardiac surgery. While EuroSCORE II and STS scores are effective in predicting short-term mortality, they lack accuracy in predicting long-term mortality, particularly in frail patients, and do not assess quality of life. New tools to evaluate frailty, such as the Clinical Frailty Scale (CFS), are now used in preoperative assessments for planned cardiac interventions. Identifying frail elderly patients early is crucial for improving patient and family information on care plans, especially in high-risk surgeries. Even in emergencies, patients must remain involved in their health decisions, and multidisciplinary collaboration is vital for improving postoperative recovery and quality of life.
Data will be collected :
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Patients aged ≥ 75 years who are affiliated with or beneficiaries of a social security scheme and undergoing emergency cardiac surgery under cardiopulmonary bypass, either immediate or urgent (relative) :
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients with Clinical Frailty Score CFS ≥ 4
Other: Phone Calls
Patients with Clinical Frailty Score CFS \< 4
Other: Phone Calls
Phone calls will be made at 3, 6, and 12 months to report quality of life scores (EuroQol EQ 5D-5L) and other postoperative data
Quality-Adjusted Life Years (QALYs) according to preoperative frailty status
QALYs over the 12-month follow-up will be estimated from EQ-5D-5L utility scores collected at baseline, Month 3, Month 6, and Month 12 together with survival data, and compared between participants with preoperative frailty (Clinical Frailty Scale ≥4) and those without frailty (Clinical Frailty Scale \<4), with adjustment for EuroSCORE II.
Time frame: Month 12
Postoperative complications
Incidence of postoperative cardiac, respiratory, renal, infectious, and neurological complications during the first 28 postoperative days.
Time frame: From surgery through,Day 28
All-cause mortality
All-cause mortality assessed during ICU stay, hospital stay, and at Month 3, Month 6, and Month 12.
Time frame: Through Month 12
EQ-5D-5L Utility Index
Health-related quality of life assessed using the EQ-5D-5L utility index derived from the French value set
Time frame: Baseline, Month 3, Month 6, and Month 12
Dialysis dependence
Dialysis dependence among participants not receiving chronic dialysis before surgery.
Time frame: Month 3, Month 6, and Month 12
Length of intensive care unit stay
Duration of postoperative ICU stay.
Time frame: From ICU admission to ICU discharge (assessed up to Day 28)
Length of hospital stay
Total postoperative hospital length of stay.
Time frame: From surgery to hospital discharge
Hospital readmissions
Number of hospital readmissions since discharge, assessed at each follow-up visit.
Time frame: Month 3, Month 6, and Month 12
Chronic postoperative pain
Presence of chronic pain related to cardiac surgery.
Time frame: Month 3, Month 6, and Month 12
Analgesic consumption
Type of analgesic medication and frequency of use since the previous follow-up assessment.
Time frame: Month 3, Month 6, and Month 12
Living situation
Living at home versus institutionalization during follow-up.
Time frame: Month 3, Month 6, and Month 12
EQ-5D-5L visual analogue scale (EQ VAS)
Self-rated health status assessed using the EQ-5D-5L visual analogue scale (0-100).
Time frame: Baseline, Month 3, Month 6, and Month 12
Plan to share: No
No publications or documents are linked to this record.
Started Dec 2025 (actual). Primary completion is estimated for Dec 2028, 36 months after the start.
Of 514 non-industry interventional studies with no phase under Frailty, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 39. This study's planned 36 months is above that.
Counting every sponsor, half of 519 studies reached it within 22 months; a quarter within 10 and three quarters within 39.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Bordeaux →